CN Patent

CN118546109A — 含氮杂环类化合物及其医药用途

Assigned to Harbin Medisan Pharmaceutical Co ltd · Expires 2024-08-27 · 2y expired

What this patent protects

本发明公开了一种含氮杂环类化合物及其医药用途，该含氮杂环类化合物结构如式(I)所示，该类化合物或其药学上可接受的盐、氘代化合物、互变异构体、内消旋体、外消旋体、立体异构体、代谢产物、代谢前体、前药或溶剂化物对PPAR具有明显的激动作用，因而可应用于制备PPAR激动剂，用于预防或治疗PPAR介导的相关疾病。

USPTO Abstract

本发明公开了一种含氮杂环类化合物及其医药用途，该含氮杂环类化合物结构如式(I)所示，该类化合物或其药学上可接受的盐、氘代化合物、互变异构体、内消旋体、外消旋体、立体异构体、代谢产物、代谢前体、前药或溶剂化物对PPAR具有明显的激动作用，因而可应用于制备PPAR激动剂，用于预防或治疗PPAR介导的相关疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN118546109A
Jurisdiction
CN
Classification
—
Expires
2024-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Harbin Medisan Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.